PerkinElmer Showcases Advancements in Imaging and Protein Analysis at Neuroscience 2007

PerkinElmer Life and Analytical Sciences, a global leader in life science research, drug discovery and cellular science, is debuting two new powerful imaging systems along with a dramatically enhanced protein analysis portfolio at The Society for Neuroscience’s 37th annual meeting in San Diego, Nov. 3-7, booth #1530.

The product launches are the culmination of significant research and development, and focus on meeting scientists’ demands for sophisticated quantitative protein analysis and imaging systems. They also leverage the Company’s strength in developing highly selective and sensitive reagents.

“Along with the Company’s commitment to advanced cellular sciences and to furthering proteomics research, we have focused our product development on meeting customers’ requirements for new systems, expanding product appeal, and addressing daily lab pressures,” said Robert F. Friel, President and Chief Operating Officer, PerkinElmer, Inc. “We have automated processes that allow tests to run overnight, helping scientists continue to meet the demanding pace of their work. The new systems also provide immediate data analysis and greater insights into disease at the cellular level through higher-quality images and analysis.”

Following PerkinElmer’s acquisition of Improvision Ltd. earlier this year, the Company integrated teams and expertise in order to develop the new UltraVIEW^® VoX, a highly flexible and sophisticated cellular imaging and analysis solution, for academic researchers in neurobiology, cancer biology, and developmental biology. The system advancements include solid state lasers, new spinning disk technology, integrated Volocity^® high-throughput 3D and 4D imaging software, adaptability to a broad range of microscopes, and an add-on FRAP Photokinesis Accessory™. All these features allow scientists to acquire, visualize, measure, track, chart and publish 4-D multi-channel images in a single confocal imaging system. The completely modular system allows scientists to custom order their equipment and software, and easily add upgrades as their research evolves.

Showcased for the first time in the U.S., the Geliance^® 1000 Imaging System also represents the sophisticated technologies in the Company's bio- imaging portfolio. With optional advanced illumination design, it quickly and accurately captures fluorescence images of multiplexed 2D gels. Geliance 1000 can also be used for a wide array of other white light, fluorescence and chemiluminescence applications in cellular, molecular and cancer research. The Geliance 1000 acquires images up to five times faster than standard scanning systems.

PerkinElmer has also introduced new reagent kits and analysis software for scientists’ proteomic research. ExacTag™ S builds upon the innovative, multiplex ExacTag platform, and is the only all-in-one solution for quantifying multiplexed protein expression from serum or plasma. ExacTag Analysis Software version 3.0 automates communication with the popular Mascot™ protein search engine from Matrix Sciences, enabling unattended, one-step protein identification and quantitation. Many researchers will want to use this product, because they can run experiments independently.

For more information about PerkinElmer’s new product launch at Neuroscience 2007, visit the article webpage.